Wendell David Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.24M | Hold |
56,376
| – | – | 0.77% | 32 |
|
|
2026
Q1 | $6.78M | Buy |
56,376
+500
| +0.9% | +$57.7K | 0.74% | 33 |
|
|
2025
Q4 | $5.88M | Buy |
55,876
+967
| +2% | +$90.8K | 0.6% | 39 |
|
|
2025
Q3 | $4.61M | Hold |
54,909
| – | – | 0.46% | 49 |
|
|
2025
Q2 | $4.35M | Hold |
54,909
| – | – | 0.44% | 51 |
|
|
2025
Q1 | $4.93M | Buy |
54,909
+4,740
| +9% | +$443K | 0.49% | 45 |
|
|
2024
Q4 | $4.99M | Sell |
50,169
-1,330
| -3% | -$137K | 0.49% | 45 |
|
|
2024
Q3 | $5.85M | Hold |
51,499
| – | – | 0.56% | 43 |
|
|
2024
Q2 | $6.38M | Sell |
51,499
-50
| -0.1% | -$6.44K | 0.65% | 39 |
|
|
2024
Q1 | $6.8M | Sell |
51,549
-143
| -0.3% | -$17.6K | 0.69% | 39 |
|
|
2023
Q4 | $5.63M | Buy |
51,692
+815
| +2% | +$84.6K | 0.61% | 40 |
|
|
2023
Q3 | $5.24M | Buy |
50,877
+238
| +0.5% | +$25.7K | 0.62% | 40 |
|
|
2023
Q2 | $5.84M | Hold |
50,639
| – | – | 0.66% | 39 |
|
|
2023
Q1 | $5.39M | Hold |
50,639
| – | – | 0.64% | 41 |
|
|
2022
Q4 | $5.62M | Sell |
50,639
-375
| -0.7% | -$38.3K | 0.69% | 40 |
|
|
2022
Q3 | $4.39M | Buy |
51,014
+200
| +0.4% | +$17.9K | 0.59% | 46 |
|
|
2022
Q2 | $4.63M | Hold |
50,814
| – | – | 0.59% | 46 |
|
|
2022
Q1 | $4.17M | Hold |
50,814
| – | – | 0.46% | 55 |
|
|
2021
Q4 | $3.89M | Sell |
50,814
-168
| -0.3% | -$13.4K | 0.39% | 60 |
|
|
2021
Q3 | $3.83M | Sell |
50,982
-920
| -2% | -$70K | 0.43% | 58 |
|
|
2021
Q2 | $4.04M | Sell |
51,902
-2,727
| -5% | -$203K | 0.45% | 56 |
|
|
2021
Q1 | $4.02M | Buy |
54,629
+206
| +0.4% | +$15.2K | 0.48% | 54 |
|
|
2020
Q4 | $4.25M | Buy |
54,423
+36
| +0.1% | +$2.75K | 0.52% | 48 |
|
|
2020
Q3 | $4.3M | Hold |
54,387
| – | – | 0.57% | 46 |
|
|
2020
Q2 | $4.01M | Buy |
54,387
+967
| +2% | +$72.8K | 0.58% | 44 |
|
|
2020
Q1 | $3.92M | Buy |
53,420
+418
| +0.8% | +$32.9K | 0.66% | 39 |
|
|
2019
Q4 | $4.6M | Hold |
53,002
| – | – | 0.63% | 44 |
|
|
2019
Q3 | $4.26M | Buy |
53,002
+211
| +0.4% | +$16.9K | 0.62% | 44 |
|
|
2019
Q2 | $4.22M | Sell |
52,791
-29
| -0.1% | -$2.22K | 0.63% | 44 |
|
|
2019
Q1 | $4.19M | Sell |
52,820
-1,759
| -3% | -$132K | 0.65% | 42 |
|
|
2018
Q4 | $3.98M | Sell |
54,579
-3,664
| -6% | -$259K | 0.72% | 42 |
|
|
2018
Q3 | $3.94M | Hold |
58,243
| – | – | 0.61% | 44 |
|
|
2018
Q2 | $3.37M | Buy |
58,243
+7,956
| +16% | +$449K | 0.58% | 48 |
|
|
2018
Q1 | $2.61M | Sell |
50,287
-2,466
| -5% | -$133K | 0.47% | 60 |
|
|
2017
Q4 | $2.83M | Hold |
52,753
| – | – | 0.49% | 56 |
|
|
2017
Q3 | $3.22M | Buy |
52,753
+2,943
| +6% | +$178K | 0.57% | 44 |
|
|
2017
Q2 | $3.05M | Sell |
49,810
-607
| -1% | -$37K | 0.57% | 43 |
|
|
2017
Q1 | $3.06M | Sell |
50,417
-967
| -2% | -$58.7K | 0.58% | 46 |
|
|
2016
Q4 | $2.89M | Sell |
51,384
-1,045
| -2% | -$61.2K | 0.57% | 49 |
|
|
2016
Q3 | $3.12M | Sell |
52,429
-315
| -0.6% | -$18.4K | 0.62% | 48 |
|
|
2016
Q2 | $2.92M | Sell |
52,744
-2,191
| -4% | -$117K | 0.57% | 50 |
|
|
2016
Q1 | $2.78M | Sell |
54,935
-251
| -0.5% | -$12.3K | 0.54% | 49 |
|
|
2015
Q4 | $2.79M | Buy |
55,186
+1,415
| +3% | +$71.3K | 0.55% | 49 |
|
|
2015
Q3 | $2.51M | Buy |
53,771
+41
| +0.1% | +$2.18K | 0.52% | 50 |
|
|
2015
Q2 | $2.92M | Hold |
53,730
| – | – | 0.57% | 49 |
|
|
2015
Q1 | $2.92M | Hold |
53,730
| – | – | 0.56% | 46 |
|
|
2014
Q4 | $2.92M | Buy |
53,730
+4,230
| +9% | +$236K | 0.57% | 45 |
|
|
2014
Q3 | $2.79M | Hold |
49,500
| – | – | 0.58% | 47 |
|
|
2014
Q2 | $2.74M | Buy |
49,500
+754
| +2% | +$41.1K | 0.58% | 48 |
|
|
2014
Q1 | $2.65M | Buy |
48,746
+608
| +1% | +$31.5K | 0.58% | 50 |
|
|
2013
Q4 | $2.3M | Sell |
48,138
-486
| -1% | -$22.2K | 0.5% | 51 |
|
|
2013
Q3 | $2.23M | Buy |
48,624
+2,384
| +5% | +$109K | 0.53% | 50 |
|
|
2013
Q2 | $2.03M | Buy |
+46,240
| New | +$2.07M | 0.51% | 53 |
|
Other funds holding MRK
ATO
Wendell David Associates's MRK Position: Q2 2026 in Review
Wendell David Associates held its Merck (MRK) position steady in Q2 2026 at 56,376 shares worth $7.24M. The position accounts for 0.77% of the portfolio, ranked #32.
Wendell David Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Wendell David Associates held 56,376 shares of Merck worth $7.24M as of Q2 2026.
- Wendell David Associates left its Merck share count unchanged in Q2 2026.
- Merck made up 0.77% of Wendell David Associates's portfolio in Q2 2026, its #32 holding.
- Wendell David Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.